Circassia Share Discussion Threads

[aspringo] 26/9/2019 14:36

Agreed. I have a couple that have become a long term cause. I'm a sucker for a good story from a believable CEO.My only hope on this share is that the price was 4 times this with just the promise of the astra deal.All that has happened, so have had to give him a chance.Good luck to you all.P.S thanks to all the posters on this board that have contributed in a thoughtful informative way, it makes a nice change from some of the boards.

[basem1] 26/9/2019 14:13

No stop losses aspringo - way to the poorhouse that ?

[aspringo] 26/9/2019 13:15

Edit: passed...oops.See its going well.

[aspringo] 26/9/2019 10:07

Have held from 60 pence, so happy to hold from here.Though i may have past away before i ever see a profit.Cheers for all the posts gents.

[zho] 26/9/2019 09:42

... and interview with Steve Harris at

[spectoacc] 26/9/2019 09:09

Good luck to you too @the abbot. IMO it's going lower but takes two to make a market.

[spectoacc] 26/9/2019 08:59

SpectoAcc initiates coverage with a "Bye", until further evidence emerges of progress.

Was underwhelmed this morning tbh, & more confused on the AZN situation - which seems to have gone from CIR having to make milestone payments, to CIR drawing down on a 5 year loan from AZN?

[mirabeau] 26/9/2019 07:52

It's heading in the right direction.

[rathean] 26/9/2019 07:50

On balance a good news story, does the extra 10 million in revenue needed to make ebitda b/e happen before the need for a fund raise? I suspect it just might, still plenty of risk here but credit to Steve and his team for the progress, especially in sorting out the mess that was China imo dyor ofc.

[zho] 26/9/2019 07:24

Loss of £19m in H1 – cash of £21m at 30/6 – but £19.8m at 30/8 so annualised rate of cash burn appears to have reduced to £7.2m.

[mirabeau] 26/9/2019 07:10

Summary and outlook

Circassia anticipates significant sales growth during the second half of 2019, with a number of factors expected to contribute to the increase. In particular, the Company expects increased Tudorza(R) revenues following the recent transfer of the product licence and initial Duaklir(R) sales later this year following its imminent launch. The Company also plans to continue its cost control, and with favourable working capital movements on Tudorza(R) sales anticipates a dramatic reduction in net cash outflow. As a result, Circassia looks forward to continuing its trajectory towards self-sustainability, with an ongoing focus on achieving positive EBITDA at approximately GBP75 million annual sales level.'

[spectoacc] 24/9/2019 13:48

One thing you might well get is "cheeaper first". Our St Helier friend has 28.5%, so 1.5% more firepower, whereas Invesco/Barnett at c.21% at last RNS - assuming he wants completely out.

That brings into play what share price level AZN accept, if they take shares. Surely they'd take shares over seeing CIR go bust.

[spectoacc] 24/9/2019 09:57

Thanks @the abbot. I don't doubt CIR will fly on any good news, but I don't think anyone knows what will happen with the AZN payments (if AZN took shares again there's potentially 50% dilution), & I don't believe Griffiths necessarily knows anything. I note he's been building stakes in a few lately, presumably in the hope one or two come off.

Still sitting on the sidelines here.

[spectoacc] 23/9/2019 08:56

@the abbot - how do you see the payments owed to AZN playing out?